Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 264
- CBD Market
European Round-Up: 5,000 UK Patients To Receive Cannabis In Ground-Breaking Trial, TV Station Invests In Cannabis, Tobacco Firm’s Cannabis Ambition, Swiss CBD Setback
A FIRST for the UK this week with the announcement that a major study into the potential benefits of cannabis for pain relief is to be launched.
- CBD Market
True north, strong, free and supporting the cannabis industry
TRUE NORTH Canadian federal budget proposes cannabis changes, plus news on lounges and edibles Three recent cannabis policy updates show Canada still has plenty of room for improvement.
- Press releases
New Poll Shows European Market Is Ready For Legal Recreational Cannabis
CURALEAF International (the “Company”), Europe’s largest vertically integrated cannabis company, welcomes the findings from a new European poll and report on the European recreational cannabis market, the first of its kind by Hanway Associates, an advisory firm specialising in strategy, research and M&A in the cannabis sector.
- CBD Market
Quanna: breaking taboos, creating a brand and building a community
Dr Dmitry Loktionov discusses the UK’s first CBD-based sexual wellness company, Quanna.
- Adult-Use
As North American Investment In EU Cannabis Industry Tops $600m, Companies Are Gearing Up For The ‘Next Wave’ Of Capital Influx
Read our latest interview with Casa Verde’s Managing Partner, Karan Wadhera, about the opportunities Europe presents for overseas investors.
- CBD Market
How long does it take to write legislation in the US Senate?
WAITING FOR 4/20? Booker and Schumer’s legalization act is almost ready The Cannabis Administration and Opportunity Act (CAOA), sponsored by Sens.
- Press releases
MGC Pharmaceuticals Enters Partnership With Sciensus Rare For The Distribution Of CannEpil And CogniCann In The EU And UK
· MGC EXECUTES supply and distribution agreement with international pharmaceuticals company Sciensus Rare. · Sciensus Rare is an established international pharmaceutical services company, specialising in the provision of rare disease medicines through a network of decentralised clinical trials, early access programs and licensed distribution programs. · Sciensus Rare appointed the exclusive distributor of MGC Pharma’s CannEpil® and CogniCann®…
- Adult-Use
Exploring the adult-use cannabis market in Europe
The new Prohibition Partners report projects that sales of adult-use cannabis in Europe could reach €1.5bn by 2026.
- Your #1 Podcast on Cannabis News
How the unique nature of the cannabis industry opened a door for fin-tech
BofC Live is a podcast from Business of Cannabis. Delivering cannabis news and exploring the companies, brands, people, and trends driving the cannabis industry.
- Medical
Cannabis oncology products to be manufactured in California
Cannabotech has partnered with NXT LVL to manufacture its medical cannabis products with eventual sales in the UK.
- Policy & Regulation
London Drug Diversion Pilot Victim Of Misinformation And ‘Backwards, Stigmatising Attitude Towards Cannabis’
IN JANUARY, news that London Mayor Sadiq Khan was planning on launching a drug diversion pilot scheme in the capital met with widespread condemnation from MPs and the media alike, with prominent voices warning it would ‘effectively decriminalise cannabis’.
- Hemp Industry
Cannabis research passes, but not banking…yet
IT AIN’T BANKING, BUT… U.S. House passes medical cannabis research bill The Medical Marijuana Research Act passed the House on Monday, in a 343-75 vote, reports Forbes.












